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INTRODUCTION
Central retinal artery occlusion (CRAO) causes painless and
sudden visual loss in the affected eye resulting in infarction
of the retina with subsequent necrosis. It accounts for about
1/10,000 visits to ophthalmologists each year (1, 2). Gener-
ally, it has a very poor prognosis. A meaningful recovery of
visual acuity occurred in only <10% of patient (3, 4). Since
von Graefe first described the CRAO in 1859, various treat-
ments have been advocated but there is none that has proven
effective.
The pathophysiology of CRAO is similar with that of cere-
bral infarction. CRAO occurs by occlusion of the central reti-
nal artery with small emboli from atherosclerotic plaque of
internal carotid artery. Based on this principle, thromboly-
sis was suggested for restoring retinal blood flow in CRAO
through dissolving the thromboemboli (5-10). We report
our CRAO cases that were treated with intra-arterial throm-
bolysus (IAT). To our knowledge, this is the first case report
in Korea.
CASE REPORTS
Case 1
A 69-yr-old man with a history of hypertension and dia-
betes mellitus was transferred to our hospital for sudden visu-
al loss in his left eye which had occurred 9 hr ago. In medical
history, he had no ophthalmic problem and had maintained
good visual acuity. On examination, vision was light-percep-
tion in left and 20/20 in right eye. Fundus examination re-
vealed white edematous retina and typical ‘‘cherry-red spot’’
as well as vessel fragmentations suggesting CRAO (Fig. 1A).
Perfusion of retina was markedly diminished with arteriove-
nous (AV) transit time of 5 min while choroidal perfusion was
normal on fundus fluorescein angiography of left eye (Fig. 1B).
There was no strabismus and ocular movement was normal.
Intraocular pressure was 9 mmHg and slit lamp examination
of anterior segment, lid, and orbit showed normal findings.
Because the neurological examination showed no abnormal-
ity and he had not recently experienced any neurological symp-
toms, we skipped the brain imaging studies which were usu-
ally performed in the stroke patients. Ten hours after symp-
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Intra-arterial Thrombolysis for Central Retinal Artery Occlusion: 
Two Cases Report
Central retinal artery occlusion (CRAO) causes severe visual loss in affected eye
and vision does not recover in more than 90% of the patients. It is believed that it
occurs by occlusion of the central retinal artery with small emboli from atheroscle-
rotic plaque of internal cerebral artery. Retina is a part of the brain, thus basically
CRAO is corresponding to acute occlusion of intracerebral artery and retinal ischemia
is to cerebral stroke. Therefore, intra-arterial thrombolysis (IAT) has been consid-
ered as a treatment method in CRAO. Recently, we treated 2 patients diagnosed as
CRAO and could achieve complete recanalization on fundus fluorescein angiogram
with IAT. Of them, one recovered visual acuity to 20/25. We report our 2 CRAO cases
treated with IAT and discuss technical aspects for IAT and management of patient.
To the best of our knowledge, this is the first Korean report of IAT for CRAO.
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tom onset, we performed cerebral angiography with biplane
angiographic unit (Integris Allura; Philips Medical Systems,
Eindhoven, Netherlands). There was no atherosclerotic lesion
in distal carotid and proximal cervical internal carotid artery
on left carotid angiogram. Internal carotid angiogram showed
no occlusion of left ophthalmic artery up to distal segment
and normal choroidal blush (Fig. 2A). We changed diagnos-
tic catheter for 6F guiding catheter (Envoy; Cordis, Warren,
New Jersey). On selective angiogram at ophthalmic artery
using a microcatheter (Excelsior SL-10; Boston Scientifics,
Natick, Massachusetts), there was no definite occlusion in
branches including ciliary arteries and muscular branches from
ophthalmic artery (Fig. 2B). We could not confirm the cen-
tral retinal artery on angiogram. After the microcatheter was
placed in proximal segment of the ophthalmic artery, uroki-
nase (Green Cross pharmacy, Yongin, Korea) and Abxicimab
(Reopro; Lilly, Indianapolis, Indiana) which are usually used
for IAT in intracerebral artery occlusion were hand-injected
slowly up to 400,000 units and 4 mg, respectively. Urokinase
was administrated firstly for finbrinolysis and Abxicimab was
added for preventing from further platelet aggregation. Their
doses were reduced due to small size and territory of central
retinal artery and for safety. Compared with before preoper-
ative angiograms, post-IAT angiography did not show the
definite changes (Fig. 2B). There was no procedure-related
complication or event.
During the procedure, we could not find any improvement
of retinal perfusion on fundus examination and the patient
had no subjective improvement of vision. After IAT, antico-
agulation was not done, systemically. One hour after throm-
bolysis, the patient experienced marked restoration of vision
and visual field. At one day after thrombolysis, his visual acu-
ity was hand motion while he could see 20/100 using his tem-
poral visual field. The fundus fluorescein angiography showed
normalized retinal arterial filling with AV transit time of 18
sec (Fig. 3). The b wave amplitude of maximal combined
Fig. 1. Fundus photography (A) and fluorescein angiography (B) before intra-arterial thrombolysis in case 1. There was white edematous
retina with typical cherry-red spot and fragmentation of retinal vessels compatible with central retinal artery occlustion (A). Retinal arterial
filling was markedly delayed with arterio-venous transit time of 5 min. The choroidal perfusion was normal (B).
A B
Fig. 2. Arterial phase and venous phase of left internal carotid angiogram (A) in case 1. Ophthalmic artery and chroidal blush were observed.
Selective angiogram before and after intra-arterial thrombolysis (B). There was no definite occlusion in ciliary arteries and other muscular
branches from ophthalmic artery. Intra-arterial thrombolysis was performed with urokinase and abxicimab.
A B
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response of electroretinogram was 331.7 uV in his right eye
and 250.2 uV in his left eye. However, he had severe macu-
lar edema on optical coherence tomography and showed no
further improvement of vision thereafter. Because there was
no newly developed neurologic sign implying brain lesions,
the brain imaging study was not performed, additionally.
Case 2
A 47-yr-old man presented with sudden decrease of visu-
al acuity in left eye for 10 hr. The best corrected visual acu-
ity of his left eye was 20/70. On ophthalmic examination 1
month ago, he could have seen 20/20 with his left eye. Eight
years ago, he had also experienced sudden visual loss in his
right eye for CRAO. At that time, because he had visited at
hospital 2 days after onset, he had not treated for visual loss
and visual acuity was no light perception.
Fundus examination revealed edematous retina without
fragmentation of vessels (Fig. 4A). On fundus fluorescein
angiography, there was a delay in arterial filling and AV tran-
sit time was 70 sec (Fig. 4B). He was diagnosed as having
CRAO and agreed to undergo IAT.
There was no steno-occlusive and remarkable lesion on caro-
tid angiogram (Fig. 5A). The selective angiogram of oph-
thalmic artery showed a choroidal blush and no occlusion in
its branches. A microcatheter was placed at the origin of oph-
thalmic artery and urokinase was hand-injected. During the
injection, his visual acuity improved and retinal perfusion
increased on fundus examination, so we stopped the IAT after
the injection of 300,000 units of urokinase (Fig. 5B).
One day after IAT, his vision improved to 20/40 and fun-
dus fluorescein angiography showed normal retinal perfusion
with AV transit time of 12 seconds (Fig. 6A). Two weeks after
IAT, his visual acuity improved to 20/25 and there was no
more retinal edema (Fig. 6B).
Fig. 3. Fundus photography (A) and fluorescein angiography (B). One day after intra-arterial thrombolysis in case 1. Perfusion of retinal
vessels were normalized and retinal color was restored to normal orange hue. However, there still remained macular edema (A). Retinal
arterial and venous filling was normalized with arterio-venous transit time was 18 sec (B). 
A B
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Fig. 4. Fundus photogrphy (A) and fluorescein angiography (B) before intra-arterial thrombolysis in case 2. There is diffuse ischemic reti-
nal edema throughout the entire fundus (A). The visual acuity was 20/70. There is delay in arterial filling and the arteriovenous transit time
is 70 sec (B).
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DISCUSSION
In results of meta-analysis of 158 IAT patients for CRAO
(11), visual improvement occurred on average in 147 patients
(93%), with 13% achieving 20/20 or better, 25% achieving
20/40 or better, and 41% achieving 20/200 or better. The
overall complication rate was 4.5% (10/220), including 1 local
hemorrhage, 5 transient ischemic attacks, 1 hypertensive crises,
1 intracerebral hemorrhage, and 2 strokes. This result sug-
gested the benefit of IAT compared with natural history and
conservative treatment of CRAO. The therapeutic time win-
dow for better outcome is unknown. Although some author
suggested that there was no correlation between outcome and
time to treatment (6), 6-12 hr of time window is generally
accepted (12-14). Visual prognosis is often poor when throm-
bolysis is administered more than 20 hr after CRAO (12-16).
In case 1, although we recanalized the central retinal artery
within 12 hr after symptom onset, the improvement of func-
tional visual outcome was limited. To our thought, the delay
from symptom onset to procedure was too long to make sig-
nificant functional improvement. In addition, the patient in
case 1 could see better immediately after thrombolysis and
his vision deteriorated after one night, which suggests that
reperfusion injury on retinal neurons could be another cause
of limited restoration. Interestingly, case 2 showed better visu-
al outcome than 1, although the time to treatment was sim-
ilar. The severity of retinal ischemia determined by pre-treat-
ment visual acuity and degree of arterial occlusion by fundus
angiography could be the major reason for better visual out-
come in case 2. Therefore, we suggest that the better visual
outcome might be achieved in cases with the shorter time
window and with milder arterial obstruction and good pre-
IAT visual acuity.
Even though we have experienced small number of cases
Fig. 5. Common carotid angiogram in case 2 (A). There was no definite occlusion and remarkable lesion in ophthalmic artery and main trunk
of intracerebral arteries. Selective angiogram of ophthalmic artery after intra-arterial thrombolysis (B). The muscular branches and ciliary
arteries were well shown.
A B
Fig. 6. Fluorescein angiography 1day after intra-arterial thrombolysis in case 2 (A). The retinal perfusion restored to normal and arteriove-
nous transit time is 12 sec. Fundus photography 2 weeks after thrombolysis (B). There is no more retinal edema suggesting previous
ischemia. The vision improved to 20/25.
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of CRAO treated with IAT, the team approach appears to be
critical in terms of managing CRAO patients. Ophthalmol-
ogists can confirm CRAO with fundus examination and flu-
orescein angiography and rule out other diseases which can
make the sudden monocular blindness. In addition, visual
outcome should be evaluated frequently by ophthalmologists
before, during, and after IAT. The North American Symp-
tomatic Carotid Endarterectomy Trial has shown the risk of
transient monocular visual loss to be about 10% after 3 yr for
patients with ipsilateral carotid artery stenosis (17, 18). There-
fore, the patients with CRAO are likely to have the risk of
future cerebral stroke. Although the risk of cerebral infarc-
tion is lower after retinal transient ischemic attack (TIA) than
that after hemispheric TIA in this study (17), neurologists
should plan the prevention strategies including control and
treatment of stroke risk factors (19). 
Compared to acute stroke, it is relatively easy to perform
IAT for CRAO. The microcatheter with S-shaped distal tip
is adequate for ophthalmic artery selection and maintenance
of stability during procedures. The microwires used for rou-
tine intracerebral procedures which have ≤0.014′ ′ in diame-
ter can be introduced into the main trunk of ophthalmic artery.
Fibrinolytic and antiplatelet agents can be also chosen like as
IAT for acute stroke. According to reports, the doses of uroki-
nase and tPA were 100,000-1,200,000 units and 10-40 mg,
respectively (11, 16). It should be usually adjusted on the basis
of revascularization of the retinal arteries evaluated on oph-
thalmoscopic examination during procedures, but it is advis-
able that the maximum dose is reduced for safety compared
with intracerebral stroke although the recanalization may be
not confirmed during IAT. Mechanical thrombolysis using
microwire with soft tip can be done in case of occlusion in
main trunk of ophthalmic artery. Other author suggested that
thrombolytics had to be administrated in a branch of exter-
nal carotid artery in case of ipsilateral internal carotid artery
occlusion or severe stenosis (16), but its efficiency remained
unknown. The recanalization of central retinal artery is not
often visualized due to small size on angiogram. Improvement
of retinal perfusion even without recanalization of this artery
can be achieved by making CRAO into branch retinal artery
occlusion and augmentation of the flow to retina via anasto-
mosis if it may recanalize other branches.
The detailed technical aspects, indications, and clinical effi-
cacy of IAT for CRAO is still not fully elucidated. The EA-
GLE (European Assessment Group for Lysis in the Eye) (20),
the first prospective randomized clinical trial evaluating the
effect of IA tPA, is ongoing. The results of this study will be
published after a few more years.
IAT might be a sole effective treatment for CRAO. There-
fore, endovascular surgeons should have an interest in this
disabling disease and participate in treatment. Technically,
IAT for CRAO is more feasible than intracerebral artery occlu-
sion but clinical significance is much different, so that it should
be performed within appropriate range of safety.
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